Not surprisingly, the level of vimentin in the patient sample was significantly upregulated compared with that in the control group (p < 0.001) as shown in Figure 2, implying that vimentin may be a potential modulator in hepatic fibrosis. The gene discussed is VIM; the disease is Hepatic fibrosis.